Canopy Growth Corp.’s chief executive officer expects one “Google-like company” to dominate the cannabis industry. His own firm may well be on its way.

Canopy’s transformative deal with Constellation Brands Inc., the maker of Corona beer, has given it legitimacy, clout and a cash hoard that has widened the gap with its competitors. The deal has boosted Canopy’s stock 56 per cent since Constellation’s $5 billion (US$3.8 billion) investment for a 38 per cent stake was announced last week. That brings its market value to $11 billion, in the same league as plane maker Bombardier Inc. and retailer Canadian Tire Corp. and about $3.7 billion more than its nearest competitor Aurora Cannabis Inc.

Eve & Co Incorporated CEO Melinda Rombouts used to grow flowers for a living. Maybe that's why she can see the vast potential of a blossoming industry where some others don't. 

"We were in seasonal flowers," she said, noting one cold May too many convinced her to get out of the flower business altogether.

"The weather was really hurting us and that's where we really decided we had to get into something different."

So Rombouts did her research and after about six months, she not only saw a future in cannabis, but saw the potential in marketing it specifically to women.  

"We really wanted to bring a genuine perspective and women can do that for women," she said. 

Aurora Cannabis Inc (TSX:ACB) (OTCQB:ACBFF) (FRA:21P) 2018 asset acquisition spree is starting to pay dividends. The company announced very material news after the bell on Wednesday; news that is significant both for its contents, and raison d’être behind the most aggressive acquisition splurge in the cannabis sector—by far.

 Today we have identified four Canadian marijuana stocks that have acquired their license to sell cannabis within the past five months. Although there are more than 100 cannabis-related companies in Canada, there are significantly fewer companies with a license to sell, which gives companies like those we have weeded out today a distinct advantage when recreational use of marijuana is legalized in Canada on October 17, 2018.

Very soon, the day that investors have long waited for will finally be here. On Oct. 17, Canada will officially allow licensed dispensaries to sell recreational marijuana to adults. This will make it the first industrialized country in the world to allow the sale of adult-use weed, and only the second overall behind Uruguay to permit recreational cannabis.

Starseed Medicinal Inc. has reached an agreement to be the medical cannabis supplier for Shoppers Drug Mart Corp.

The agreement is subject to Health Canada’s approval of Shoppers Drug Mart’s application to be a licensed producer. The products are expected to be sold online due to current regulations restricting the sale of medical marijuana in retail pharmacies.

“We are thrilled to be partnering with Canada’s leading pharmacy network,” said Angelo Tsebelis, president of Starseed, in a news release. “Shoppers Drug Mart has taken a leadership role to validate cannabinoid therapy. We are excited to be working together as Starseed continues to expand its reach in the paid benefits space.”

CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST), one of Canada's leading licensed producers and most trusted brands of cannabis, announced today that the company has signed an agreement with the Ontario Cannabis Retail Corporation (OCRC), operating as the Ontario Cannabis Store (OCS), to supply a broad range of adult-use products from all three of the Company's new recreational cannabis brands – liiv, Xscape and Synr.g. The Company brings more than 40 years of pharmaceutical and healthcare experience to the cannabis industry and is applying this knowledge to its recreational cannabis products.

Some marijuana sector stocks are up slightly after Ontario announced supply agreements with 26 licensed producers in preparation for legalization of recreational pot this fall.

Smaller producers which signed initial agreements with the Ontario Cannabis Store, which will be selling pot online starting on Oct. 17, saw bigger lifts in the volatile sector.

Shares of licensed producer Beleave Inc. were up roughly 16 per cent to $1.55 in Toronto while Newstrike Brands Ltd.'s stock was up more than 21 per cent to $0.67.

Ontario announced late Monday that it had signed agreements with 26 licensed producers such as Canopy Growth Corp., Aurora Cannabis and Aphria Inc. as well as smaller players including Starseed Medicinal Inc. and Solace Health Inc.

DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the "Company") and LIFT CO. LTD. ("Lift & Co.") today announce a partnership that will see Lift & Co. train Delta 9 retail store employees across Canada using Lift & Co.'s leading-edge Cannabis Retail Training Certification (the "Certification").

The Certification was created by Lift & Co. through an exclusive partnership with MADD Canada. The Certification combines Lift & Co.'s years of experience educating legal cannabis consumers and MADD Canada's recognized expertise in responsible consumption into a self-guided online curriculum delivered through Lift & Co.'s retail education platform, with in-class components administered by MADD Canada.

Companies to Supply a Broad Variety of Products for the Emerging Adult Consumer Market

Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to confirm it, and its wholly-owned subsidiary MedReleaf, have entered into supply agreements with the Ontario Cannabis Stores, a key market in the Company's adult consumer use strategy. When government-run online sales commence on October 17, Aurora and MedReleaf will supply a broad range of dried flower and higher margin products, such as pre-rolls, oils and capsules.